ANIP

NASDAQStock

ANI Pharmaceuticals, Inc.

$72.82-3.46 (-4.54%)

52-Week Range

$57.27

$98.81

Key Stats

Market Cap

1.6B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46

Volume

295.2K

Avg Volume

420.1K

Performance

-9.29%

-9.83%

-26.64%

YTD

-7.57%

+14.59%

+76.76%

+119.60%

Price Chart

ETF Exposure

ANIP is held by 113 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	10	$736	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	6	$486	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	5	$367	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	2	$163	$9.5M	0.12%
MMTM	State Street SPDR S&P 1500 Momentum Tilt ETF	0.00%	19	$1K	$163.7M	0.12%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.00%	1,229	$94K	$12.10B	0.03%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	40	$3K	$733.2M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	122	$9K	$1.69B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	352	$27K	$3.28B	0.20%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	5	$379	$694.1M	0.23%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	2	$115	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	5	$381	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	9	$649	$81.7M	0.11%

PreviousPage 3 of 3

About ANIP ETF Exposure

ANI Pharmaceuticals, Inc. (ANIP) is held by 113 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.6B, ANIP is a widely held institutional stock. The stock currently trades at $72.82. Investors can gain exposure to ANIP through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ANIP, sorted by portfolio weight.